Combination inhaled steroid and long-acting beta-agonist versus tiotropium for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Cates, Christopher J ^a   Lasserson, Toby J ^a   Poole, Phillippa ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LONG ACTING DRUG; STEROID; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFECT; HUMAN; LUNG FUNCTION; PNEUMONIA; QUALITY OF LIFE; REVIEW;

EID: 70049100577     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007891     Document Type: Review

References (13)

1. Appleton S, Poole P, Smith B, Veale A, Lasserson TJ, Chan MMK, Cates CJ. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001104.pub2]
2. Appleton S, Jones T, Poole P, Pilotto L, Adams R, Lasserson TJ, et al.Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001387.pub2]
3. Appleton S, Jones T, Poole P, Lasserson TJ, Adams R, Smith B, et al.Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006101]
4. Barr RG, Bourbeau J, Camargo CA. Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002876.pub2]
5. Effing T, Monninkhof EEM, van der Valk PP, Zielhuis GGA, Walters EH, van der Palen JJ. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD002990.pub2] (Pubitemid 351805368)
6. Global Initiative for Chronic Obstructive Lung Disease. http: //www.goldcopd.com [Accessed 18th February 2009].
7. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008].. Available from www.cochrane-handbook.org [Accessed 26th February 2009].
8. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD003793.pub2] (Pubitemid 44781736)
9. Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003794.pub3] (Pubitemid 351805193)
10. Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus longacting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006829] (Pubitemid 351805193)
11. Nannini LJ, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD006826] (Pubitemid 351805193)
12. Singh S, Amin AV, Loke YK. Long-termuse of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease. Archives of internal medicine 2009;169(3):219-229
13. Yang IA, Fong K, Sim EH, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD002991.pub2] (Pubitemid 351805800)